Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Triple Negative Breast Neoplasms
×
capivasertib
×
Clear all
Filters
3
NCT04556773
2025-12-17
DB-08
AstraZeneca
Phase 1
Active not recruiting
138 enrolled